Evaluation of Antimicrobial Susceptibility to Amikacin Liposome Inhalation Suspension and Relapse/Reinfection in Pulmonary M. Abscessus Disease
Siegel S, Brown-Elliott B, Strnad L, Fuss C, Griffith D, Wallace, Jr. R, Philley J, Winthrop K. Evaluation of Antimicrobial Susceptibility to Amikacin Liposome Inhalation Suspension and Relapse/Reinfection in Pulmonary M. Abscessus Disease. 2020, a4495-a4495. DOI: 10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a4495.Peer-Reviewed Original Research